These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35261724)

  • 1. Advances in Nanoparticles for Effective Delivery of RNA Therapeutics.
    Byun MJ; Lim J; Kim SN; Park DH; Kim TH; Park W; Park CG
    Biochip J; 2022; 16(2):128-145. PubMed ID: 35261724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.
    Kulkarni JA; Witzigmann D; Chen S; Cullis PR; van der Meel R
    Acc Chem Res; 2019 Sep; 52(9):2435-2444. PubMed ID: 31397996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Review of pH-Responsive Organic-Inorganic Hybrid Nanoparticles for RNAi-Based Therapeutics.
    Wang L; Yan Y
    Macromol Biosci; 2021 Sep; 21(9):e2100183. PubMed ID: 34160896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle Delivery Platforms for RNAi Therapeutics Targeting COVID-19 Disease in the Respiratory Tract.
    Zhang Y; Almazi JG; Ong HX; Johansen MD; Ledger S; Traini D; Hansbro PM; Kelleher AD; Ahlenstiel CL
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Budding Alliance of Nanotechnology in RNA Interference Therapeutics.
    Kumawat A; Dapse P; Kumar N; Mishra DK; Maheshwari R; Bhattacharya P; Tekade RK
    Curr Pharm Des; 2018; 24(23):2632-2643. PubMed ID: 30084328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small interfering RNAs (siRNAs) in cancer therapy: a nano-based approach.
    Mahmoodi Chalbatani G; Dana H; Gharagouzloo E; Grijalvo S; Eritja R; Logsdon CD; Memari F; Miri SR; Rad MR; Marmari V
    Int J Nanomedicine; 2019; 14():3111-3128. PubMed ID: 31118626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNAi-based therapeutics and tumor targeted delivery in cancer.
    Kara G; Calin GA; Ozpolat B
    Adv Drug Deliv Rev; 2022 Mar; 182():114113. PubMed ID: 35063535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
    Varshosaz J; Taymouri S
    Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Advances in siRNA Delivery Systems for Prostate Cancer Therapy.
    Aghamiri S; Raee P; Shahmohamadnejad S; Shabani S; Ghorbani J; Sameni M; Ebrahimi MT
    Curr Pharm Biotechnol; 2022; 23(4):579-593. PubMed ID: 34132181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
    Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
    Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional nanostructures for effective delivery of small interfering RNA therapeutics.
    Hong CA; Nam YS
    Theranostics; 2014; 4(12):1211-32. PubMed ID: 25285170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in mRNA non-viral delivery approaches.
    Ibba ML; Ciccone G; Esposito CL; Catuogno S; Giangrande PH
    Adv Drug Deliv Rev; 2021 Oct; 177():113930. PubMed ID: 34403751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycation-based nanoparticle delivery for improved RNA interference therapeutics.
    Howard KA; Kjems J
    Expert Opin Biol Ther; 2007 Dec; 7(12):1811-22. PubMed ID: 18034647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
    Revia RA; Stephen ZR; Zhang M
    Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-viral vectors for RNA delivery.
    Yan Y; Liu XY; Lu A; Wang XY; Jiang LX; Wang JC
    J Control Release; 2022 Feb; 342():241-279. PubMed ID: 35016918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA cancer nanomedicine: nanotechnology-mediated RNA therapy.
    Ferdows BE; Patel DN; Chen W; Huang X; Kong N; Tao W
    Nanoscale; 2022 Mar; 14(12):4448-4455. PubMed ID: 35080555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-mediated selective delivery of short RNA therapeutics in cancer cells.
    Esposito CL; Catuogno S; de Franciscis V
    J RNAi Gene Silencing; 2014; 10():500-6. PubMed ID: 25414727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticles-Based Strategies to Improve the Delivery of Therapeutic Small Interfering RNA in Precision Oncology.
    Huang J; Xiao K
    Pharmaceutics; 2022 Jul; 14(8):. PubMed ID: 36015212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.